This patient initially presented in 2006 with stage IIB right breast cancer (ER+, HER2-) and underwent a right partial mastectomy and axillary lymph node dissection, adjuvant chemotherapy, adjuvant radiation, and endocrine therapy for five years. This evidence concerns the gene ERBB2 and breast carcinoma.